Svoboda M, Cundrle Jr I, Plutinsky M, Homolka P, Mitas L, Chovanec Z
ERJ Open Res. 2024; 10(4).
PMID: 39286055
PMC: 11403594.
DOI: 10.1183/23120541.00978-2023.
Jeong Y, Lee H, Jang H, Park D, Choi Y, Lee S
J Thorac Dis. 2024; 16(2):1054-1062.
PMID: 38505088
PMC: 10944722.
DOI: 10.21037/jtd-23-1563.
Agostoni P, Mapelli M, Salvioni E, Mattavelli I, Banfi C, Bonomi A
Respir Res. 2024; 25(1):82.
PMID: 38331869
PMC: 10851544.
DOI: 10.1186/s12931-023-02602-3.
Krinski G, Bertin L, Pimpao H, Silva H, Tavares B, Lunardelli L
J Clin Med. 2023; 12(23).
PMID: 38068366
PMC: 10707053.
DOI: 10.3390/jcm12237314.
Wasserstein M, Lachmann R, Hollak C, Barbato A, Gallagher R, Giugliani R
Orphanet J Rare Dis. 2023; 18(1):378.
PMID: 38042851
PMC: 10693698.
DOI: 10.1186/s13023-023-02983-0.
Lung function trajectories in patients with idiopathic pulmonary fibrosis.
Neely M, Hellkamp A, Bender S, Todd J, Liesching T, Luckhardt T
Respir Res. 2023; 24(1):209.
PMID: 37612608
PMC: 10463468.
DOI: 10.1186/s12931-023-02503-5.
Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry.
King C, White E, Aryal S, Shlobin O, Singhal A, Brown A
Heliyon. 2023; 9(8):e18618.
PMID: 37600402
PMC: 10432603.
DOI: 10.1016/j.heliyon.2023.e18618.
The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity.
Priel E, Diab N, Patel M, Wahab M, Freitag A, OByrne P
PLoS One. 2023; 18(8):e0289540.
PMID: 37552695
PMC: 10409289.
DOI: 10.1371/journal.pone.0289540.
HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development.
Cook C, Craddock V, Ram A, Abraham A, Dhillon N
Compr Physiol. 2023; 13(3):4659-4683.
PMID: 37358518
PMC: 10693986.
DOI: 10.1002/cphy.c210049.
Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults.
Lachmann R, Diaz G, Wasserstein M, Armstrong N, Yarramaneni A, Kim Y
Orphanet J Rare Dis. 2023; 18(1):94.
PMID: 37098529
PMC: 10131350.
DOI: 10.1186/s13023-023-02700-x.
Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.
Lee J, White E, Freiheit E, Scholand M, Strek M, Podolanczuk A
Chest. 2022; 162(3):603-613.
PMID: 35337809
PMC: 9808640.
DOI: 10.1016/j.chest.2022.03.025.
Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation.
Diaz Del Valle F, Zakrajsek J, Min S, Koff P, Bell H, Kincaid K
Chest. 2022; 162(3):556-568.
PMID: 35271841
PMC: 9470742.
DOI: 10.1016/j.chest.2022.02.049.
Pulmonary functional assessment: longitudinal study after treatment of pulmonary tuberculosis.
Nishi M, Mancuzo E, Sulmonett N, de Almeida I, Cesar A, Miranda S
Rev Inst Med Trop Sao Paulo. 2021; 63:e65.
PMID: 34406290
PMC: 8376278.
DOI: 10.1590/S1678-9946202163065.
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.
Baughman R, Shlobin O, Gupta R, Engel P, Stewart J, Lower E
Chest. 2021; 161(2):448-457.
PMID: 34363816
PMC: 9005858.
DOI: 10.1016/j.chest.2021.07.2162.
Translation, cross-cultural adaptation, and measurement properties of the Brazilian-Portuguese version of the idiopathic pulmonary fibrosis-specific version of the Saint George's Respiratory Questionnaire (SGRQ-I) for patients with interstitial lung....
Aguiar W, Mantoani L, Silva H, Zamboti C, Garcia T, Cavalheri V
Braz J Phys Ther. 2021; 25(6):794-802.
PMID: 34348865
PMC: 8721060.
DOI: 10.1016/j.bjpt.2021.06.008.
The need for race-specific reference equations for pulmonary diffusing capacity for nitric oxide.
Zavorsky G, Almamary A, Alqahtani M, Shan S, Gardenhire D
BMC Pulm Med. 2021; 21(1):232.
PMID: 34256739
PMC: 8278768.
DOI: 10.1186/s12890-021-01591-7.
Risk of Lung Allograft Dysfunction Associated With Infection.
Le Pavec J, Pradere P, Gigandon A, Dauriat G, Dureault A, Aguilar C
Transplant Direct. 2021; 7(3):e675.
PMID: 34113715
PMC: 8184025.
DOI: 10.1097/TXD.0000000000001128.
One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency.
Diaz G, Jones S, Scarpa M, Mengel K, Giugliani R, Guffon N
Genet Med. 2021; 23(8):1543-1550.
PMID: 33875845
PMC: 8354848.
DOI: 10.1038/s41436-021-01156-3.
Hb-adjusted DLCO with GLI reference predicts long-term survival after HSCT in children.
Lee H, Kim K, Kim S, Lee J, Yoon J, Chung N
Bone Marrow Transplant. 2021; 56(8):1929-1936.
PMID: 33782549
DOI: 10.1038/s41409-020-01202-9.
Carbohydrate antigen 15-3 as a marker of disease severity in patients with chronic hypersensitivity pneumonitis.
Gomes P, Soares M, Marchenta M, Meirelles G, Ferreira R, Botelho A
J Bras Pneumol. 2021; 47(1):e20200589.
PMID: 33681879
PMC: 8332669.
DOI: 10.36416/1806-3756/e20200589.